Document type
Book partVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/21373
Involvement of nicotinic receptors in methamphetamine and MDMA induced neurotoxicity: Pharmacological studies
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
During the last years, our emphasis has focused in the study of the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (METH) on central nervous system and their pharmacological prevention. In the process of this research, we have used a semipurified synaptosomal preparation from striatum of mice or rats as a reliable in vitro model to study reactive oxygen species (ROS) production by these amphetamine derivatives, which is well correlated with their dopaminergic injury in in vivo models. Using this preparation we have demonstrated that blockade of alpha7 nicotinic receptors with methyllycaconitine (MLA) and memantine (MEM) prevents ROS production induced by MDMA and METH. Studies at molecular level showed that both, MDMA and METH, displaced competitively the binding of radioligands for homomeric alpha7 and heteromeric nAChRs, indicating that they can directly interact with them. In all the cases MDMA displayed higher affinity than METH and it was higher for heteromeric than for alpha7 subtype. Preincubation of differentiated PC12 cells with MDMA or METH induces nicotinic acetylcholine receptors (nAChR) up-regulation in a concentration- and time-dependent manner, as many nicotinic ligands do, supporting their functional interaction with nAChRs. Such interaction expands the pharmacological profile of amphetamines and can account for some of their effects.
Description
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32392
Subject
Subject (English)
Citation
Citation
ESCUBEDO RAFA, Elena, et al. Involvement of nicotinic receptors in methamphetamine and MDMA induced neurotoxicity: Pharmacological studies. Recent Advances in Pharmaceutical Sciences. 2011. Vol. Chapter 7, num. 155-174, pags. Editor: Diego Muñoz-Torrero. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/21373